title: Metabotropic glutamate receptors: new targets for the control of tumor growth?
abstract: Cancer stem cells are currently a target for the treatment of malignant tumors. Transformed neural stem-progenitor cells of the brain subventricular zone and the external granular layer of the cerebellum are the putative cells of origin of malignant gliomas and medulloblastomas, which are the most frequent malignant brain tumors in adults and children, respectively. The proliferation of neural stem-progenitor cells is regulated by metabotropic glutamate (mGlu) receptors, which are G-protein-coupled receptors that are activated by glutamate, the major excitatory neurotransmitter of the CNS. At least two receptor subtypes - mGlu(3) and mGlu(4) receptors - control the proliferation of brain tumor cells, whereas mGlu(1) receptors have been implicated in the development of melanomas. We believe that individual mGlu receptor subtypes represent new potential targets for the treatment of several malignant tumors, including brain tumors.
authors: Istituto Neurologico Mediterraneo Neuromed, Località Camerelle, Pozzilli 86079, Italy. ferdinandonicoletti@hotmail.com
authors: Ferdinando
authors: F
authors: Nicoletti
authors: Antonietta
authors: A
authors: Arcella
authors: Luisa
authors: L
authors: Iacovelli
authors: Giuseppe
authors: G
authors: Battaglia
authors: Felice
authors: F
authors: Giangaspero
authors: Daniela
authors: D
authors: Melchiorri
mesh_terms: D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D049109:Cell Proliferation; D002648:Child; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D016503:Drug Delivery Systems; D019008:Drug Resistance, Neoplasm; D015870:Gene Expression; D006801:Humans; D008024:Ligands; D008545:Melanoma / Q000188:drug therapy / Q000503:physiopathology; D014411:Neoplastic Stem Cells / Q000187:drug effects; D018094:Receptors, Metabotropic Glutamate / Q000145:classification / Q000187:drug effects* / Q000378:metabolism; D012878:Skin Neoplasms / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000970:Antineoplastic Agents; D008024:Ligands; D018094:Receptors, Metabotropic Glutamate